These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 25976389)
1. The chronic lymphocytic leukaemia market. Esencay M; Hamad B Nat Rev Drug Discov; 2015 Jun; 14(6):381-2. PubMed ID: 25976389 [No Abstract] [Full Text] [Related]
2. A challenge to the claims that fludarabine and cyclophosphamide is the new standard treatment for chronic lymphocytic leukaemia. Haines I; Elliott P; Stanley R Intern Med J; 2009 Apr; 39(4):269-71. PubMed ID: 19402870 [No Abstract] [Full Text] [Related]
3. Guidelines on the diagnosis and management of chronic lymphocytic leukaemia. Oscier D; Fegan C; Hillmen P; Illidge T; Johnson S; Maguire P; Matutes E; Milligan D; Br J Haematol; 2004 May; 125(3):294-317. PubMed ID: 15086411 [No Abstract] [Full Text] [Related]
4. Long-term follow up of frontline therapy with fludarabine and cyclophosphamide in chronic lymphocytic leukemia: impact of biological parameters on clinical outcome. De Padua L; Laurenti L; Falcucci P; D'arena G; Vannata B; Innocenti I; Autore F; Piccirillo N; Za T; Marietti S; Efremov DG; Sica S Ann Hematol; 2014 Jul; 93(7):1261-2. PubMed ID: 24306088 [No Abstract] [Full Text] [Related]
5. Simultaneous occurrence of chronic lymphocytic leukaemia and acute lymphoblastic leukaemia. Bueno J; Irriguible MD; Palacio C Haematologica; 2002 Apr; 87(4):EIM11. PubMed ID: 11940498 [No Abstract] [Full Text] [Related]